Gould Capital, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gould Capital, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,145
+18.2%
5000.0%0.01%
+22.2%
Q2 2023$11,125
+2.7%
5000.0%0.01%
+12.5%
Q1 2023$10,830
+6.6%
5000.0%0.01%0.0%
Q4 2022$10,155
-21.9%
5000.0%0.01%
-27.3%
Q3 2022$13,000
+8.3%
5000.0%0.01%
+10.0%
Q2 2022$12,000
+9.1%
5000.0%0.01%
+25.0%
Q1 2022$11,000
+10.0%
5000.0%0.01%
+14.3%
Q4 2021$10,0005000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders